Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept in Uveitis-Related CNV
NCT02934841Phase 2Unknown
- Sponsor
- Chongqing Medical University
- Start
- Nov 2016
- Primary completion
- Mar 2018
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 2 trial of conbercept in choroidal neovascularization (CNV), sponsored by Chongqing Medical University. Status: unknown.
02
Drugs
conbercept
03
Conditions
choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT02934841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02934841.